Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Trading Update

30 Sep 2014 07:00

RNS Number : 9598S
Royal Bank of Scotland Group PLC
30 September 2014
 



The Royal Bank of Scotland Group plc ("RBS")

 

Q3 2014 Trading Update and Presentation at Bank of America Merrill Lynch Banking & Insurance Conference

 

30 September 2014

 

Presentation at Bank of America Merrill Lynch Banking & Insurance Conference

 

Ross McEwan, RBS Chief Executive, will present at the Bank of America Merrill Lynch Banking & Insurance Conference in London on Tuesday 30 September 2014 at 9.30am (UK time). 

 

A live audio webcast and accompanying slides will be available on our website www.rbs.com/ir shortly before the presentation commences.

 

Q3 2014 Trading Update

 

RBS today provides an update on Q3 2014 financial performance.

 

· Q3 2014 has seen continued improvement in economic conditions and asset prices in our key markets, including Ireland. This has supported a further quarter of strong operating performance by RBS Capital Resolution ("RCR"). We anticipate that RCR will record net impairment provision releases in the region of £0.5bn in Q3 2014.

 

· RCR's future overall costs and speed of wind-down remain subject to significant potential volatility. The potential exists, if market conditions remain favourable, for RCR to incur limited future impairments and disposal losses, and an accelerated timetable to achieve its wind-down goals.

 

· Rising Irish residential property prices combined with pro-active debt management has resulted in lower arrears in Ulster (excluding RCR), within Personal & Business Banking. As a result we expect Ulster to record net provision releases in the region of £0.3bn in Q3 2014. The potential exists for further releases in future, if market conditions continue to improve.

 

· There has been an absence of large one-off impairments and lower levels of new non-performing loans in the rest of RBS's business during Q3 2014.

 

· RBS now expects to significantly outperform its previous guidance of c£1bn total impairments for FY 2014. Previously disclosed uncertainties remain, particularly relating to conduct and litigation matters.

 

· Corporate & Institutional Banking revenues have been weaker than anticipated in the third quarter.

 

· RBS took advantage of improved market prices to dispose of c€9bn legacy available for sale debt securities. These disposals generated a loss of around £0.2bn in Centre revenues. We expect these transactions to be moderately capital ratio accretive.

 

The figures quoted in this statement are preliminary estimates and unaudited. RBS will release its Q3 2014 Interim Management Statement on 31 October 2014.

 

 

For further information:

 

Investor Relations

Richard O'Connor

Head of Investor Relations

+44 (0) 20 7672 1758

 

Media Relations

+44 (0) 131 523 4205

 

If you would like a copy of this presentation in a different format (eg. large print, audio or Braille) please contact the Investor Relations team on +44 20 7672 1758 or investor.relations@rbs.com.

 

This release contains 'forward-looking statements' as that term is defined in the United States Private Securities Litigation Reform Act of 1995. Forward looking statements are statements that are not historical facts and can be identified by the use of forward-looking terminology such as statements that include the words 'expect', 'estimate', 'project', 'anticipate', 'believes', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'will', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on such expressions or by the forward looking nature of discussions of strategy, plans, targets and intentions. . These statements are based on current plans, estimates and projections, and are subject to inherent risks, uncertainties and other factors which could cause actual results to differ materially from the future results expressed or implied by such forward-looking statements. The forward-looking statements contained in this release speak only as of the date of this announcement, and the Group does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The information, statements and opinions contained in this document do not constitute a public offer under any applicable legislation or an offer to sell or solicitation of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKKDPPBKKKCN
Date   Source Headline
20th Sep 20197:00 amRNSAppointment of CEO
12th Sep 20192:29 pmRNSForm 8.3 - Accesso Technology Group plc
9th Sep 20198:30 amRNSBarclays Global Financial Services Conference
5th Sep 20192:10 pmRNSPublication of Suppl.Prospcts
4th Sep 20197:00 amRNSUpdate on Charges Related to PPI
3rd Sep 201912:49 pmRNSForm 8.3 - Accesso Technology Group plc
30th Aug 20193:03 pmRNSTotal Voting Rights
29th Aug 20195:16 pmRNSDirector/PDMR Shareholding
29th Aug 20193:13 pmRNSDividend Declaration
14th Aug 20192:53 pmRNSDirector/PDMR Shareholding
12th Aug 20192:58 pmRNSForm 8.3 - Accesso Technology Group plc
5th Aug 20197:15 amRNSDirector Declaration
5th Aug 20197:00 amRNSAppointment of Non-Executive Director
2nd Aug 20192:43 pmRNSPublication of a Prospectus
2nd Aug 20197:31 amRNSNatWest Markets N.V. Interim Results 2019
2nd Aug 20197:00 amRNSInterim Results 2019 - Part 2 of 2
2nd Aug 20197:00 amRNSInterim Results 2019 - Part 1 of 2
31st Jul 20195:41 pmRNSDirector/PDMR Shareholding
31st Jul 201912:43 pmRNSTotal Voting Rights
25th Jul 20193:07 pmRNSForm 8.3 - Accesso Technology Group PLC
19th Jul 20197:00 amRNSRoss McEwan announced CEO National Australia Bank
16th Jul 201910:22 amRNSDirector Declaration
3rd Jul 20191:58 pmRNSForm 8 (DD) - Premier Technical Services Group plc
1st Jul 20191:54 pmRNSDirector/PDMR Shareholding
28th Jun 20192:45 pmRNSDividend Declaration
28th Jun 20191:19 pmRNSTotal Voting Rights
24th Jun 20198:00 amRNSRBS Investor Seminar : Technology & Innovation
20th Jun 20192:33 pmRNSTakeover Panel PremierTechnical Services Group plc
18th Jun 20195:09 pmRNSPublication of Suppl.Prospcts
17th Jun 20197:00 amRNSImpact of Alawwal bank / Saudi British Bank merger
11th Jun 20193:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20193:33 pmRNSConfirmation re stated post-offer intentions
31st May 20195:06 pmRNSDividend Declaration
31st May 20193:04 pmRNSTotal Voting Rights
31st May 201912:39 pmRNSDirector/PDMR Shareholding
20th May 20196:04 pmRNSForm 8.3 - WYG PLC
20th May 201910:37 amRNSPublication of Suppl.Prospcts
16th May 20194:11 pmRNSRBS Group welcomes credit ratings action by S&P
16th May 201911:40 amRNSAcknowledgment of two settlements on FX trading
10th May 20193:12 pmRNSDirector/PDMR Shareholding
3rd May 201912:10 pmRNSRBSG pricing of US$1.25bn of Senior Notes
2nd May 201910:25 amRNSDirector/PDMR Shareholding
30th Apr 20193:24 pmRNSTotal Voting Rights
29th Apr 201911:07 amRNSPublication of Suppl.Prospcts
26th Apr 20197:00 amRNSQ1 Interim Management Statement
25th Apr 20196:03 pmRNSResult of AGM
25th Apr 20192:00 pmRNSAGM Statement
25th Apr 20197:00 amRNSDirectorate Change
24th Apr 20193:03 pmRNSDividend Declaration
23rd Apr 201912:46 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.